NCT05918913 2025-09-05Expanded Access Program for RevumenibSyndax PharmaceuticalsNo longer available1 FDA
NCT03594162 2021-12-03Compassionate Use of CAR T Cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety SwitchUNC Lineberger Comprehensive Cancer CenterNo longer available
NCT01200017 2021-05-27Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell TransplantUniversity of California, San FranciscoNo longer available
NCT03114228 2019-10-15An Expanded Treatment Protocol (ETP) of Midostaurin (PKC412) in Patients 18 Years of Age or Older With Newly-diagnosed FLT3-mutated Acute Myeloid Leukemia (AML)NovartisNo longer available
NCT00423826 2016-02-29Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseaseBarbara Ann Karmanos Cancer InstituteNo longer available